
Site burden is now measured through satisfaction surveys, in-the-moment check-ins, and adoption patterns, but each method catches a different moment, and the gaps between them decide whether teams can act before burden becomes risk.
Schulman IRB-an industry IRB in customer service and technology-announced the launch of its Central Neurology Review (CNR) service.
Through its partnership with the National Biomedical Research Ethics Council (NBREC), a 501(c) non-profit, Schulman developed CNR to assist research institutions and biopharma and device companies.
Read the full release






